GGrantIndex
← Leaderboards

Geisinger Clinic

Danville, PA

Compare ↔
$130,184,582
Total funding
63
Grants

Funding over time

peak $11.1M · FY2006–25
$20M$15M$10M$5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$118,305,946 · 53
CDC$5,743,487 · 3
AHRQ$3,750,700 · 5
DOD$2,384,449 · 2

By mechanism

R01$64,179,444 · 28
U01$29,076,981 · 7
UG1$14,346,835 · 1
U10$3,324,543 · 1
R33$2,856,380 · 2
R18$2,501,217 · 2

Investigators at Geisinger Clinic

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Matthew Oetjens$2,954,1361 gr2Samuel S Gidding$2,021,6642 gr3Scott Myers$2,019,4001 gr4Christopher F. Chabris$1,613,3671 gr5Ana Morales Reyes$1,578,7361 gr6Carlo R Bartoli$1,318,8951 gr7Eric David Carruth$1,249,9731 gr8Andres Moreno De Luca$666,5801 gr

Emerging Leaders

6–10 yrs in

1Alanna K Rahm$3,691,9981 gr2Laney K Jones$1,989,6273 gr3Melissa Poulsen$1,491,9163 gr4Amy Curry Sturm$1,424,6031 gr5Tullika Garg$271,6981 gr

All-Time

Most funded here, all years

1David H. Ledbetter$12,416,6124 gr2Christa Lese Martin$7,142,1123 gr3Marc S. Williams$4,769,6392 gr4Alanna K Rahm$3,691,9981 gr5Matthew Oetjens$2,954,1361 gr6Nikolaos Tapinos$2,124,1342 gr7Samuel S Gidding$2,021,6642 gr8Scott Myers$2,019,4001 gr

Largest grants

MENTAL HEALTH DISORDERS, SUICIDE RISK, AND TREATMENT SEEKING AMONG FORMERLY DEPLOYED NATIONAL GUARD AND RESERVE SERVICE MEMBER SEEN IN NON-VA FACILIT$2,261,852
· FY2015 · Department of the Army
Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders$1,866,316
U01 · FY2021 · MH
Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders$1,845,135
U01 · FY2022 · MH
Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders$1,826,721
U01 · FY2023 · MH
Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders$1,738,336
U01 · FY2019 · MH
Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders$1,723,751
U01 · FY2020 · MH
Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP)$1,653,934
UG1 · FY2025 · CA
Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP)$1,568,477
UG1 · FY2022 · CA
Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP)$1,554,577
UG1 · FY2023 · CA
Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP)$1,491,429
UG1 · FY2024 · CA
Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP)$1,273,784
UG1 · FY2021 · CA
Geisinger Cancer Institute Oncology Research Program$1,100,072
UG1 · FY2018 · CA
Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP)$1,099,310
UG1 · FY2020 · CA
Geisinger eGenonic Medicine (GeM) Program$1,063,790
U01 · FY2013 · HG
Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP)$1,051,861
UG1 · FY2019 · CA
Geisinger eGenonic Medicine (GeM) Program$1,009,234
U01 · FY2014 · HG
Component A: A multi-level study of community context and type 2 diabetes and coronary heart disease using electronic health record and new primary data across nested geographies in Pennsylvania$999,966
U01 · FY2020 · DP
Real-time genetic diagnosis at the point of care$975,703
R01 · FY2021 · HG
Geisinger Cancer Institute Oncology Research Program$955,000
UG1 · FY2014 · CA
Evaluation of a peer recovery support program adapted to target retention in clinic-based medication for opioid use disorder treatment$943,458
R61 · FY2023 · DA